New research has highlighted the value of recycling general anaesthetic used in routine operations.
In the UK, healthcare accounts for more than five per cent of national greenhouse gas emissions, and as much as 10 per cent in the US. Inhaled general anaesthetics are particularly potent greenhouse gases and as little is metabolised almost all that is administered is breathed out to end up in the atmosphere. The commonly used anaesthetic agents have been considered to vary considerably from as little as 1.5 for sevoflurane to more than 60 kg carbon dioxide equivalence for an hour s anaesthetic with desflurane. However, research led by a team from the University of Exeter have discovered that the original assumptions failed to consider the manufacture of the anaesthetics, questioning the validity of the initial assumptions and the subsequent conclusions.
Washington [US], February 24 (ANI): Progressive exercise and early mobilisation are among the elements of rehabilitation programs that may improve recovery for people who are hospitalised with severe COVID-19, new research has concluded.
TRT Digital Debates To Host Talk On Vaccine Diplomacy
Discussion to be broadcast live on YouTube, Twitter, Facebook. TRT World Forum s Digital Debates series will continue on Wednesday with a discussion on the COVID-19 pandemic and vaccine diplomacy.
The session features Irshad Ali Shaikh, WHO Turkey health security team head; Bharat Pankhania, senior clinical lecturer at University of Exeter Medical School; and Ahmed Ogwell Ouma, deputy director of the Africa Centres for Disease Control and Prevention.
It will be hosted by Talip Kucukcan, a former member of Turkey s parliament and currently professor of sociology at Marmara University and a senior fellow at the TRT World Research Center.
How rehabilitation could help people with COVID-19 recover -- evidence reviewed eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
E-Mail
Scientists have identified a way to rescue muscle cells that have genetically mutated, paving the way to a possible new treatment for rare childhood illness such as Duchenne Muscular Dystrophy (DMD).
The study, led by the Universities of Exeter and Nottingham, is published in the
Proceedings of the National Academies of Sciences, USA. The research used novel drugs being developed at the University of Exeter, which metabolically reprogram the cellular energy production centres in muscle cells, by providing them with a fuel source to generate metabolic energy.
DMD is a genetic condition caused by a mutation in a gene called dystrophin which results in progressive irreversible muscular degeneration and weakening. Its symptoms include muscle atrophy leading to a loss of the ability to walk in children for which there is no known cure. Currently, the condition is treated with steroids, such as prednisone, but they can stop working and side-effects are common. The resear